Advertisement
Canada markets close in 3 hours 50 minutes

  • S&P/TSX

    22,346.13
    +86.66 (+0.39%)
     

  • S&P 500

    5,196.98
    +16.24 (+0.31%)
     

  • DOW

    38,915.36
    +63.09 (+0.16%)
     

  • CAD/USD

    0.7297
    -0.0024 (-0.33%)
     

  • CRUDE OIL

    78.38
    -0.10 (-0.13%)
     

  • Bitcoin CAD

    87,523.67
    +224.41 (+0.26%)
     

  • CMC Crypto 200

    1,320.93
    -44.19 (-3.24%)
     

  • GOLD FUTURES

    2,323.10
    -8.10 (-0.35%)
     

  • RUSSELL 2000

    2,077.10
    +16.42 (+0.80%)
     

  • 10-Yr Bond

    4.4230
    -0.0660 (-1.47%)
     

  • NASDAQ

    16,393.54
    +44.30 (+0.27%)
     

  • VOLATILITY

    13.47
    -0.02 (-0.15%)
     

  • FTSE

    8,313.67
    +100.18 (+1.22%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • CAD/EUR

    0.6769
    -0.0023 (-0.34%)
     
MARKETS LIVE BLOG:

STOCKS TRADE HIGHER; DISNEY SINKS AFTER EARNINGS

Apple reportedly designing its own AI chips for data centres

PCLOF & TLRY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / April 3, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

PharmaCielo Ltd. (PCLOF)

Class Period: June 21, 2019 - March 2, 2020

Deadline: May 5, 2020
For more info: www.bgandg.com/pclof

ADVERTISEMENT

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC; (2) PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp.; (3) PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed; (4) the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants; (5) PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and (6) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Tilray, Inc. (TLRY)

Class Period: January 15, 2019 - March 2, 2020

Deadline: May 5, 2020
For more info: www.bgandg.com/tlry

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the purported advantages of the ABG Agreement were significantly overstated; (2) the underperformance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/583037/PCLOF-TLRY-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-of-Class-Actions-and-Encourages-Investors-to-Contact-the-Firm